Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
about
Intratympanic glucocorticoids for sudden sensorineural hearing lossChemical screening for hair cell loss and protection in the zebrafish lateral lineMicrofabricated reciprocating micropump for intracochlear drug delivery with integrated drug/fluid storage and electronically controlled dosingRisk of sudden sensorineural hearing loss in stroke patients: A 5-year nationwide investigation of 44,460 patients.Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss.Comparison of simultaneous systemic steroid and hyperbaric oxygen treatment versus only steroid in idiopathic sudden sensorineural hearing loss.Assessing the cause of tinnitus for therapeutic options.Corticosteroid therapy for hearing and balance disordersMarkers of cochlear inflammation using MRI.Sudden hearing loss subsequent to diarrhea: what is the missing link?Efficacy of three drugs for protecting against gentamicin-induced hair cell and hearing losses.Intratympanic steroid treatment for idiopathic sudden sensorineural hearing loss after failure of intravenous therapy.Drug delivery for treatment of inner ear disease: current state of knowledgeTopical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial.Emerging pharmacotherapy of tinnitus.Principles of local drug delivery to the inner ear.Inner ear drug delivery for auditory applications.Sudden sensorineural hearing loss: subclinical viral and toxoplasmosis infections as aetiology and how they alter the clinical course.Clinical practice guideline: sudden hearing loss.Steroids for treatment of sudden sensorineural hearing loss: a meta-analysis of randomized controlled trials.A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment.Recovery of hearing in Cisplatin-induced ototoxicity in the Guinea pig with intratympanic dexamethasone.Evaluation of intratympanic dexamethasone for treatment of refractory sudden sensorineural hearing loss.Dendrogenin A and B two new steroidal alkaloids increasing neural responsiveness in the deafened guinea pig.Intratympanic dexamethasone in sudden sensorineural hearing loss: A systematic review and meta-analysis.Sudden Sensorineural Hearing Loss: Primary Care UpdateIssues, indications, and controversies regarding intratympanic steroid perfusionIntratympanic dexamethasone on cochlear blood flow in Guinea pigs.Are intra-tympanically administered steroids effective in patients with sudden deafness? Implications for current clinical practice.Intratympanic steroids for sudden sensorineural hearing loss: a systematic review.Early posttreatment audiometry underestimates hearing recovery after intratympanic steroid treatment of sudden sensorineural hearing loss.Analysis of frequency loss as a prognostic factor in idiopathic sensorineural hearing loss.Intratympanic steroids as primary initial treatment of idiopathic sudden sensorineural hearing loss. The Hospital Universitario Ramón y Cajal experience and review of the literature.Bilateral sudden hearing loss following habitual abortion: a case report and review of literature.Function of the audiovestibular system in children with systemic lupus erythematosus.Safety of Repeated-Dose Intratympanic Injections with AM-101 in Acute Inner Ear Tinnitus.Preoperative steroids for hearing preservation cochlear implantation: A review.Sudden hearing loss associated with methylphenidate therapy.Chronic myeloid leukemia presenting with visual and auditory impairment in an adolescent: an insight to management strategies.Dexamethasone concentration gradients along scala tympani after application to the round window membrane.
P2860
Q24240942-47923E3A-2480-45FE-9DD9-3AE7E71A4DE1Q28468560-2DF249C7-5E91-43A1-A07D-27B0C9156556Q30361679-30D723D4-6245-420F-B0ED-2AC20B3ACA39Q30373911-5619E489-160B-47C4-91EE-66729B0ED3E2Q30379423-B1C38BEB-B9E9-4EAA-A87B-E4182A375D5EQ30404545-C36535DD-1C80-4C83-98BE-68A3901B8C1DQ30428296-1590DAC1-69D9-48EC-80CF-B60F4EFACF88Q30439597-62A6CF1B-1DE5-4B30-B3CF-5A2216EE3CF9Q30442598-8FB6EAEA-185D-4787-83B3-2E85DD0F6854Q30444390-46830329-EE7E-4DF6-A937-EED385B0AEEDQ30452815-2B2BDB7C-D4A1-4E66-B337-CC5A375CE7A3Q30454208-6A6EAFCD-648E-4E04-9917-ABE43193D252Q30476020-E68C842D-4AAB-4C33-A312-EB28F4D31F65Q30478217-7A8CD231-6982-40D8-B5A5-DB7BD5CA04CBQ30478378-335508D1-6EF4-4D0E-A6AB-4B9D5921C27DQ30478838-AA5A3909-F51E-40BD-9575-49F3902679FCQ30484636-61DEAB60-7354-41E9-BAF5-2A5B7BD3327EQ34169555-E86848E3-F571-4DC9-9E20-5BE306CCD60AQ34258137-5699D3CC-0554-49F5-9562-2B02E7D18F22Q34430062-38D00C5B-1D30-46F8-93D1-1F9749FA521CQ34537290-C64A828E-FABC-4028-A1BE-1F19DD3CB71CQ35629544-08B3EF3B-C339-4559-B4C2-B90B4D6DE79BQ35810136-26803A8B-F59A-409F-9FB1-6CC6370E0133Q35885126-A00E19C8-2E14-4A4B-8119-071B24218AC1Q36197780-135E0D6D-5460-4800-B49E-3A34B4290601Q37055368-D96A9DB2-C185-430C-8D0D-99771682ECDDQ37146991-14B2AABA-4721-44A2-80CE-731C2EAEFDA0Q37468583-BAEC46F8-EC92-4A27-AEF0-346675D8F415Q37919754-2B4959A7-D65C-4D44-8F7A-3BC440FA76D0Q37923244-B7794557-5BE5-42A7-9025-38614B28A642Q37967815-9E69FF57-C31F-439C-978D-4739F86A26EAQ38002114-FC7D715A-8412-40FC-A60B-BE0B4680BC0DQ38068727-98097276-354D-4AB7-8343-DA361CF12B52Q38138087-2B3F3A54-0B78-43CA-ABCD-4D6685F93906Q38209891-F223860F-1AFC-4EFC-8DB0-A1BB52B44B72Q38728148-C28D381E-5742-448D-A4C8-D8ADEF4855B4Q38749399-A41490B8-504D-4506-A4D9-F6B625D12A4FQ39218705-35343DF2-ED8C-47B5-9636-09612CF1387EQ41158667-78CDC1A9-C329-49E5-A9D9-E25D8406A2A4Q41641420-5120DE32-7B6E-447C-8A58-EBAC2BA1B61E
P2860
Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Intratympanic dexamethasone fo ...... r failure of systemic therapy.
@ast
Intratympanic dexamethasone fo ...... r failure of systemic therapy.
@en
type
label
Intratympanic dexamethasone fo ...... r failure of systemic therapy.
@ast
Intratympanic dexamethasone fo ...... r failure of systemic therapy.
@en
prefLabel
Intratympanic dexamethasone fo ...... r failure of systemic therapy.
@ast
Intratympanic dexamethasone fo ...... r failure of systemic therapy.
@en
P2093
P2860
P1433
P1476
Intratympanic dexamethasone fo ...... r failure of systemic therapy.
@en
P2093
David S Haynes
Kenneth Watford
Matthew O'Malley
Robert F Labadie
Seth Cohen
P2860
P356
10.1097/01.MLG.0000245058.11866.15
P407
P577
2007-01-01T00:00:00Z